Shopping Cart 0
Cart Subtotal
AED 0

Omega Pharma NV - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report

Summary

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Omega Pharma NV (Omega or 'the company'), is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.

Scope

- Detailed information on Omega Pharma NV required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis

- An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments

- Intelligence on Omega Pharma NV's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Omega Pharma NV, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Omega Pharma NV and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Omega Pharma NV as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Omega Pharma NV's business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 4

Omega Pharma NV: Company Overview 7

Omega Pharma NV: Overview and Key Facts 7

Omega Pharma NV: Overview 7

Omega Pharma NV: Key Facts 7

Omega Pharma NV: Key Employees 9

Omega Pharma NV: Major Products and Services 10

Omega Pharma NV: Company History 11

Omega Pharma NV: Management Statement 14

Omega Pharma NV: Locations and Subsidiaries 15

Omega Pharma NV: Key Competitors 16

Omega Pharma NV: Company Analysis 17

Omega Pharma NV: Business Description 17

Omega Pharma NV: SWOT Analysis 18

Omega Pharma NV: SWOT Overview 18

Omega Pharma NV: Strengths 18

Omega Pharma NV: Weaknesses 19

Omega Pharma NV: Opportunities 19

Omega Pharma NV: Threats 20

Omega Pharma NV: Corporate Financial Deals Activity 21

Omega Pharma NV: Financial Deals Overview 21

Omega Pharma NV: Targets and Partners 23

Omega Pharma NV: Top Deals 2014-2018YTD 24

Omega Pharma NV: Partnership 25

Omega Pharma NV: Private Equity and Ownership 26

Appendix 27

Contact Us 27

Methodology 27

About MarketLine 28


List Of Figure

List of Figures

Figure 1: Omega Pharma NV: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Omega Pharma NV: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Omega Pharma NV: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 4: Omega Pharma NV: Partnership Trend by Deal Type (2014-YTD 2018)

Figure 5: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 6: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Omega Pharma NV: Key Facts

Table 2: Omega Pharma NV: Key Employees

Table 3: Omega Pharma NV: Locations and Subsidiaries

Table 4: Omega Pharma NV: Key Competitors

Table 5: Omega Pharma NV: Deal Activity by Deal Type-Volume (TTM )

Table 6: Omega Pharma NV: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Omega Pharma NV: Targets and Partners

Table 8: Omega Pharma NV: Top Deals 2014-2018YTD

Table 9: Omega Pharma NV: Partnership Volume a

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report

Summary

Omega Pharma NV-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

Omega Pharma NV (Omega or 'the company'), is a subsidiary of Perrigo Company plc, is engaged in the development, marketing and sales of over-the-counter (OTC) pharmaceutical products. It also offers pain relief products, eye care products, sleep aid and anti-snoring products, slimming products, and home diagnostics. The company primarily operates in Europe. Omega is headquartered in Nazareth, Belgium.

Scope

- Detailed information on Omega Pharma NV required for business and competitor intelligence needs

- A study of the major internal and external factors affecting Omega Pharma NV in the form of a SWOT analysis

- An in-depth view of the business model of Omega Pharma NV including a breakdown and examination of key business segments

- Intelligence on Omega Pharma NV's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about Omega Pharma NV, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Omega Pharma NV and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess Omega Pharma NV as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on Omega Pharma NV's business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 4

Omega Pharma NV: Company Overview 7

Omega Pharma NV: Overview and Key Facts 7

Omega Pharma NV: Overview 7

Omega Pharma NV: Key Facts 7

Omega Pharma NV: Key Employees 9

Omega Pharma NV: Major Products and Services 10

Omega Pharma NV: Company History 11

Omega Pharma NV: Management Statement 14

Omega Pharma NV: Locations and Subsidiaries 15

Omega Pharma NV: Key Competitors 16

Omega Pharma NV: Company Analysis 17

Omega Pharma NV: Business Description 17

Omega Pharma NV: SWOT Analysis 18

Omega Pharma NV: SWOT Overview 18

Omega Pharma NV: Strengths 18

Omega Pharma NV: Weaknesses 19

Omega Pharma NV: Opportunities 19

Omega Pharma NV: Threats 20

Omega Pharma NV: Corporate Financial Deals Activity 21

Omega Pharma NV: Financial Deals Overview 21

Omega Pharma NV: Targets and Partners 23

Omega Pharma NV: Top Deals 2014-2018YTD 24

Omega Pharma NV: Partnership 25

Omega Pharma NV: Private Equity and Ownership 26

Appendix 27

Contact Us 27

Methodology 27

About MarketLine 28


List Of Figure

List of Figures

Figure 1: Omega Pharma NV: Deal Activity by Deal Type-Volume (TTM )

Figure 2: Omega Pharma NV: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: Omega Pharma NV: Partnership Volume and Value Trend (2014-YTD 2018)

Figure 4: Omega Pharma NV: Partnership Trend by Deal Type (2014-YTD 2018)

Figure 5: Omega Pharma NV: Private Equity and Ownership Volume and Value Trend (2014-YTD 2018)

Figure 6: Omega Pharma NV: Private Equity and Ownership Volume by Deal Type (2014-YTD 2018)


List Of Table

List of Tables

Table 1: Omega Pharma NV: Key Facts

Table 2: Omega Pharma NV: Key Employees

Table 3: Omega Pharma NV: Locations and Subsidiaries

Table 4: Omega Pharma NV: Key Competitors

Table 5: Omega Pharma NV: Deal Activity by Deal Type-Volume (TTM )

Table 6: Omega Pharma NV: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: Omega Pharma NV: Targets and Partners

Table 8: Omega Pharma NV: Top Deals 2014-2018YTD

Table 9: Omega Pharma NV: Partnership Volume a

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS